27th week of 2017 patent applcation highlights part 9 |
Patent application number | Title | Published |
20170189309 | COMPOSITIONS AND METHODS FOR TREATING KERATINOUS SUBSTRATES | 2017-07-06 |
20170189310 | AQUEOUS COLORANT COMPOSITION AND USE THEREOF | 2017-07-06 |
20170189311 | NAIL POLISH COMPOSITIONS | 2017-07-06 |
20170189312 | COMPOSITIONS CONTAINING POLYCARBODIIMIDES AND AMINO COMPOUNDS FOR ENHANCED COLOR RETENTION AND DURABILITY | 2017-07-06 |
20170189313 | COMPOSITIONS CONTAINING POLYCARBODIIMIDES AND LATEX POLYMERS FOR TREATING KERATINOUS SUBSTRATES | 2017-07-06 |
20170189314 | COMPOSITIONS AND METHODS FOR TREATING KERATINOUS SUBSTRATES | 2017-07-06 |
20170189315 | SYSTEMS AND METHODS FOR IMPROVING THE APPEARANCE OF SKIN | 2017-07-06 |
20170189316 | HYBRID NAIL COATING SYSTEMS AND METHODS OF THEIR USE | 2017-07-06 |
20170189317 | COMPOSITIONS AND METHODS FOR IMPROVING THE APPEARANCE OF THE SKIN | 2017-07-06 |
20170189318 | Skin, Nail and Hair Topical Antimicrobial Methods Using Formulations Containing Organosilane Quaternaries | 2017-07-06 |
20170189319 | COMPOSITIONS CONTAINING POLYCARBODIIMIDES AND AMINO SILICONE COMPOUNDS FOR TREATING KERATINOUS SUBSTRATES | 2017-07-06 |
20170189320 | SYSTEMS AND METHODS FOR IMPROVING THE APPEARANCE OF THE SKIN | 2017-07-06 |
20170189321 | SYSTEMS AND METHODS FOR IMPROVING THE APPEARANCE OF THE SKIN | 2017-07-06 |
20170189322 | COMPOSITIONS CONTAINING FILM FORMING DISPERSION OF PARTICLES IN AQUEOUS PHASE AND HIGH LEVELS OF PLANT OIL | 2017-07-06 |
20170189323 | ALL-NATURAL SUNSCREEN | 2017-07-06 |
20170189324 | COSMETIC COMPOSITION FOR MOISTURIZING KERATINIC TISSUE | 2017-07-06 |
20170189325 | Topical Compositions | 2017-07-06 |
20170189326 | Topical Antiaging Polyphenol Compositions | 2017-07-06 |
20170189327 | COMPOSITION, CONTAINING TYNDALLIZED LACTOBACILLUS DEAD CELLS AS ACTIVE INGREDIENT, FOR SKIN MOISTURIZING OR WRINKLE IMPROVEMENT | 2017-07-06 |
20170189328 | Veterinary Pharmaceutical Composition and Use Thereof | 2017-07-06 |
20170189329 | METHOD OF PREPARING A PHARMACEUTICAL COMPOSITION | 2017-07-06 |
20170189330 | COUGH SYRUP CONTAINING AMBROXOL HYDROCHLORIDE | 2017-07-06 |
20170189331 | Probiotic Confection and Lipid Compositions | 2017-07-06 |
20170189332 | COMPOSITION AND METHOD FOR MANAGEMENT OF DIABETES OR PRE-DIABETES | 2017-07-06 |
20170189333 | Aqueous gel composition and its use | 2017-07-06 |
20170189334 | PEPTIDE HYDROGEL PROPERTIES AND ITS APPLICATIONS | 2017-07-06 |
20170189335 | DOSAGE AND ADMINISTRATION FOR PREVENTING CARDIOTOXICITY IN TREATMENT WITH ERBB2-TARGETED IMMUNOLIPOSOMES COMPRISING ANTHRACYCLINE CHEMOTHERAPEUTIC AGENTS | 2017-07-06 |
20170189336 | CO-GRANULES OF XANTHAN GUM AND ACACIA GUM | 2017-07-06 |
20170189337 | Therapeutic Compositions for Treatment of Human Immunodeficiency Virus | 2017-07-06 |
20170189338 | TABLETING AGENT HAVING A LOW WATER CONTENT, AND METHOD FOR THE PRODUCTION THEREOF | 2017-07-06 |
20170189339 | ABUSE DETERRENT IMMEDIATE RELEASE BIPHASIC MATRIX SOLID DOSAGE FORM | 2017-07-06 |
20170189340 | ANTIEMETIC EXTENDED RELEASE SOLID DOSAGE FORMS | 2017-07-06 |
20170189341 | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HELICOBACTER PYLORI | 2017-07-06 |
20170189342 | Methods and Compositions for the Treatment of Seizure-Related Disorders | 2017-07-06 |
20170189343 | DRUG CARRIER FOR TUMOR-SPECIFIC TARGETED DRUG DELIVERY AND USE THEREOF | 2017-07-06 |
20170189344 | HIGHLY DRUG-LOADED POLY(ALKYL 2-CYANOACRYLATE) NANOCAPSULES | 2017-07-06 |
20170189345 | NANOENCAPSULATION OF ANTIGEN-BINDING MOLECULES | 2017-07-06 |
20170189346 | UNIFORM FILMS FOR RAPID-DISSOLVE DOSAGE FORM INCORPORATING ANTI-TACKING COMPOSITIONS | 2017-07-06 |
20170189347 | TRANSDERMAL DELIVERY SYSTEM | 2017-07-06 |
20170189348 | SYSTEMS AND METHODS FOR LONG TERM TRANSDERMAL ADMINISTRATION | 2017-07-06 |
20170189349 | Onychomycosis Treatment System and Method | 2017-07-06 |
20170189350 | METHODS OF TREATMENT OF TEMOZOLOMIDE-RESISTANT GLIOMA USING COENZYME Q10 | 2017-07-06 |
20170189351 | CAPSULE DOSAGE FORM OF METOPROLOL SUCCINATE | 2017-07-06 |
20170189352 | EPINEPHRINE FORMULATIONS | 2017-07-06 |
20170189353 | DOSAGE REGIMEN FOR A S1P RECEPTOR AGONIST | 2017-07-06 |
20170189354 | PHARMACEUTICAL COMPOSITION COMPRISING RIMEPORIDE FOR TREATING DISEASES ASSOCIATED WITH INSULIN RESISTANCE AND BETA-CELL DYSFUNCTION | 2017-07-06 |
20170189355 | USE OF KUKOAMINE A AND KUKOAMINE B | 2017-07-06 |
20170189356 | SOLID ORAL FORMULATION OF FENRETINIDE | 2017-07-06 |
20170189357 | METHODS OF LIMITING MORBIDITY IN HEMOGLOBINOPATHIES | 2017-07-06 |
20170189358 | SORBIC AND BENZOIC ACID AND DERIVATIVES THEREOF ENHANCE THE ACTIVITY OF A NEUROPHARMACEUTICAL | 2017-07-06 |
20170189359 | Graphene Nanostructure-Based Pharmaceutical Composition for Preventing or Treating Neurodegenerative Diseases | 2017-07-06 |
20170189360 | METHOD, COMPOSITION AND PACKAGE FOR BOWEL CLEANSING | 2017-07-06 |
20170189361 | EYE DROPS FOR TREATING DRY EYE | 2017-07-06 |
20170189362 | TUNEABLE DELIVERY OF NANOPARTICLE BOUND ACTIVE PLASMIN FOR THE TREATMENT OF THROMBOSIS | 2017-07-06 |
20170189363 | GASTRIC ACID MODULATORS FOR ORAL DELIVERY OF PEPTIDES AND PROTEINS | 2017-07-06 |
20170189364 | COMPOSITIONS COMPRISING ORNITHINE AND PHENYLACETATE OR PHENYLBUTYRATE FOR TREATING HEPATIC ENCEPHALOPATHY | 2017-07-06 |
20170189365 | Treatment and Prevention of Liver Disease Associated with Parenteral Nutrition (PN) | 2017-07-06 |
20170189366 | METHOD FOR TREATING DISORDERS RELATED TO COMPLEMENT ACTIVATION | 2017-07-06 |
20170189367 | Lobaplatin Crystal, Preparation Method And Pharmaceutical Application | 2017-07-06 |
20170189368 | STABLE FORMULATIONS FOR LYOPHILIZING THERAPEUTIC PARTICLES | 2017-07-06 |
20170189369 | MULTI-ARM POLYMERIC ALKANOATE CONJUGATES | 2017-07-06 |
20170189370 | FLUORINATED BENZOFURAN DERIVATIVES | 2017-07-06 |
20170189371 | HNF4-alpha ANTAGONIST AND USE THEREOF | 2017-07-06 |
20170189372 | USE OF SUBSTITUTED CHROMAN COMPOUNDS | 2017-07-06 |
20170189373 | Terpene Control in Scaleable Cannabinoid Medicinal Formulations | 2017-07-06 |
20170189374 | ZALTOPROFEN AND MUSCLE RELAXANT COMBINATIONS | 2017-07-06 |
20170189375 | METHOD OF TREATMENT OF A MUCOPOLYSACCHARIDOSIS | 2017-07-06 |
20170189376 | BUTYROYLOXYMETHYL DIETHYL PHOSPHATE COMPOUNDS AND USES THEREOF | 2017-07-06 |
20170189377 | CHLOROPHYLL C CONTAINING DEGRANULATION SUPPRESSOR | 2017-07-06 |
20170189378 | COMPOUNDS FOR THE TREATMENT OF CANCERS ASSOCIATED WITH HUMAN PAPILLOMAVIRUS | 2017-07-06 |
20170189379 | COMBINATION THERAPIES WITH CURAXINS | 2017-07-06 |
20170189380 | TRYPTAMINE-BASED SHIP INHIBITORS FOR THE TREATMENT OF CANCER | 2017-07-06 |
20170189381 | PRIMARY AMINES AND DERIVITVES THEREOF AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | 2017-07-06 |
20170189382 | COMPOUNDS FOR TREATING BRAIN CANCER | 2017-07-06 |
20170189383 | PPAR COMPOUNDS FOR USE IN THE TREATMENT OF FIBROTIC DISEASES | 2017-07-06 |
20170189384 | REVERSING INTESTINAL INFLAMMATION BY INHIBITING RETINOIC ACID METABOLISM | 2017-07-06 |
20170189385 | PHARMACEUTICAL COMPOSITIONS COMPRISING RIFAXIMIN AND AMINO ACIDS, PREPARATION METHODS AND USE THEREOF | 2017-07-06 |
20170189386 | TETRAHYDROCARBOLINE DERIVATIVE | 2017-07-06 |
20170189387 | PROLYL HYDROXYLASE INHIBITORS AND METHODS OF USE | 2017-07-06 |
20170189388 | NICOTINE REPLACEMENT THERAPY PRODUCTS COMPRISING SYNTHETIC NICOTINE | 2017-07-06 |
20170189389 | MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS | 2017-07-06 |
20170189390 | TETRAHYDROISOQUINOLIN-1-ONE DERIVATIVE OR SALT THEREOF | 2017-07-06 |
20170189391 | Protein kinase C inhibitor for treating triple-negative breast cancer | 2017-07-06 |
20170189392 | LIPOSOME OF IRINOTECAN OR IRINOTECAN HYDROCHLORIDE AND PREPARATION METHOD THEREOF | 2017-07-06 |
20170189393 | COMPOSITIONS AND METHODS FOR MINIMIZING OR REVERSING AGONIST-INDUCED DESENSITIZATION | 2017-07-06 |
20170189394 | NOVEL POLYMORPHIC FORMS OF VORTIOXETINE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS | 2017-07-06 |
20170189395 | DIKETOPIPERAZINE MICROPARTICLES WITH DEFINED SPECIFIC SURFACE AREAS | 2017-07-06 |
20170189396 | METHODS AND COMPOSITIONS FOR TREATING DRY EYE DISEASE AND OTHER EYE DISORDERS | 2017-07-06 |
20170189397 | HEADACHE PRE-EMPTION BY DIHYDROERGOTAMINE TREATMENT DURING HEADACHE PRECURSOR EVENTS | 2017-07-06 |
20170189398 | METHODS AND COMPOSITIONS FOR SLEEP DISORDERS AND OTHER DISORDERS | 2017-07-06 |
20170189399 | NEPRILYSIN INHIBITORS | 2017-07-06 |
20170189400 | SUBSTITUTED INDOL-5-OL DERIVATIVES AND THEIR THERAPEUTIC APPLICATIONS | 2017-07-06 |
20170189401 | 2,3-DISUBSTITUTED 1 -ACYL-4-AMINO-1,2,3,4-TETRAHYDROQUINOLINE DERIVATIVES AND THEIR USE AS BROMODOMAIN INHIBITORS | 2017-07-06 |
20170189402 | SOLID DOSAGE FORMS | 2017-07-06 |
20170189403 | TREATMENT OR PREVENTION OF NON-INFLAMMATORY NEURONAL DAMAGE FROM BRAIN TRAUMA AND STROKES USING MENTHOL, LINALOOL AND/OR ICILIN | 2017-07-06 |
20170189404 | BRUTON'S TYROSINE KINASE AS ANTI-CANCER DRUG TARGET | 2017-07-06 |
20170189405 | ARF6 INHIBITORS AND METHODS OF SYNTHESIS AND USE THEREOF | 2017-07-06 |
20170189406 | DEUTERATED BARICITINIB | 2017-07-06 |
20170189407 | Modulators of Androgen Synthesis | 2017-07-06 |
20170189408 | NOVEL PHARMACEUTICAL COMPOSITION | 2017-07-06 |